Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stoke Therapeutics (STOK), Embecta Corporation (EMBC...

Wall Street Analysts Are Bullish on Top Healthcare Picks

An announcement from Embecta Corporation ( ($EMBC) ) is now available. On March 19, 2026, Embecta announced a definitive agreement to acquire priva...

Market Cap	$522.91M	P/E Ratio	3.15
52W High	$15.55	52W Low	$8.47
Div Yield	60.0%	Payout Ratio	89.5%
EPS Growth 3Y	-25.2%	52W Position	6.0%
Overall Score	45	Value Score	80
Quality Score	36	Technical Score	20

EPS Current Est	$2.82	EPS Next Est	$2.86
EPS Growth Est	+1.4%	DPS Growth 3Y	58.7%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EMBC	$8.90	+0.74%	230.96K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EMBC	$8.90	+0.7%	230.96K
3
4
5
6

EMBC

EMBC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Embecta Corp. Data in Excel

Get Embecta Corp. Data in Excel